(Q34276405)

1 August 2017

title

Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input (English)

1 reference

1 August 2017

0 references

Goadsby PJ

1

1 reference

1 August 2017

Classey JD

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 August 2017

1 reference

1 August 2017

volume

122

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

491-498

1 reference

Plasma Serotonin in Migraine and Stress

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

"In" vivo method for calibrating electromagnetic flowmeter probes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Naratriptan: biological profile in animal models relevant to migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Rizatriptan has central antinociceptive effects against durally evoked responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

1 reference

7 January 2021

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

The pharmacology of headache

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Effects of locus coeruleus stimulation on carotid vascular resistance in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Migraine--current understanding and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Serotonin and migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

The mode of action of sumatriptan is vascular? A debate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Effect of serotonin in migraine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

SUMATRIPTAN: a receptor-targeted treatment for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

The 5-HT1D receptor antagonist GR 127,935 is an agonist at cloned human 5-HT1D alpha receptor sites

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Characterization of ligand binding properties of the 5-HT1D receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Differential pharmacology between the guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D-selective ligands)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Development and characterisation of human 5-HT1B- or 5-HT1D-receptor specific antibodies as unique research tools

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperature.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

Tolerability of sumatriptan: clinical trials and post-marketing experience

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2803%2900570-0

7 January 2021

10.1016/S0306-4522(03)00570-0

Identifiers

DOI

1 reference

1 August 2017

1 reference